|
Volumn 31, Issue 7, 2001, Pages 603-609
|
Gemfibrozil improves insulin sensitivity and flow-mediated vasodilatation in type 2 diabetic patients
c
University of Padova
*
(Italy)
|
Author keywords
Diabetes mellitus; Endothelium; Insulin action; Lipoproteins; Triglycerides
|
Indexed keywords
GEMFIBROZIL;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
INTERMEDIATE DENSITY LIPOPROTEIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
PLACEBO;
TRIACYLGLYCEROL;
ARTERY BLOOD FLOW;
ARTICLE;
BRACHIAL ARTERY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOUBLE BLIND PROCEDURE;
ECHOGRAPHY;
HUMAN;
INSULIN SENSITIVITY;
LIPID METABOLISM;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TRIACYLGLYCEROL BLOOD LEVEL;
VASODILATATION;
AGED;
ANTILIPEMIC AGENTS;
ARTERIOSCLEROSIS;
BLOOD CIRCULATION;
DIABETES MELLITUS, TYPE 2;
ENDOTHELIUM, VASCULAR;
GEMFIBROZIL;
HUMANS;
HYPERTRIGLYCERIDEMIA;
INSULIN;
INSULIN RESISTANCE;
TRIGLYCERIDES;
VASODILATION;
|
EID: 0034945479
PISSN: 00142972
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2362.2001.00856.x Document Type: Article |
Times cited : (71)
|
References (33)
|